Advances in Pharmacokinetics

Pharmacokinetics describes how the body affects a specific xenobiotic/chemical after administration through the mechanisms of absorption and distribution, as well as the metabolic changes of the substance in the body (e.g. by metabolic enzymes such as cytochrome P450 or glucuronosyltransferase enzymes), and the effects and routes of excretion of the metabolites of the drug.[1] Pharmacokinetic properties of chemicals are affected by the route of administration and the dose of administered drug. These may affect the absorption rate.

Components of the Book:
  • Chapter 1
    The blind spot in high-dose tigecycline pharmacokinetics in critically ill patients: membrane adsorption during continuous extracorporeal treatment
  • Chapter 2
    Pharmacokinetics of Canakinumab in children younger than 2 years old with CAPS
  • Chapter 3
    The pharmacokinetics of tigecycline in critically ill adult patients undergoing CVVHD
  • Chapter 4
    Pharmacokinetics of antituberculosis drugs in critically ill patients with tuberculosis and acute respiratory failure
  • Chapter 5
    Pharmacokinetics, safety and tolerability of human recombinant alkaline phosphatase in healthy volunteers
  • Chapter 6
    Pharmacokinetics of meropenem during continuous renal replacement therapy in critically ill patients
  • Chapter 7
    Pharmacokinetics of daptomycin in patients undergoing low-flow continuous venovenous hemodiafiltration
  • Chapter 8
    Pharmacodynamics and pharmacokinetics of ciprofloxacin during sustained low-efficiency dialysis
  • Chapter 9
    Pharmacokinetics of caffeine administered in a time-release versus regular tablet form
  • Chapter 10
    Pharmacokinetics and the optimal regimen for levofloxacin in critically ill patients receiving continuous hemodiafiltration
Readership: Students, academics, teachers and other people attending or interested in Pharmacokinetics.
Patrick M Honore, ICU Department, Universitair Ziekenhuis Brussel–Vrije Universiteit Brussel University, Jette, Belgium

J Kalabus, Novartis Institutes for Biomedical Research, New Jersey, USA

E Peters, Radboudumc, Nijmegen, the Netherlands

TI Ide, Hyogo College of Medicine, Nishinomiya City, Japan

K Olsen, University of Nebraska Medical Center, Omaha, USA

Adam M Gonzalez, University of Central Florida, Orlando, USA

and more...
This Book

333pp. Published August 2017

Scientific Research Publishing, Inc.,USA.

Category:Biomedical & Life Sciences

ISBN: 978-1-61896-422-9

(Hardcover) USD 109.00

ISBN: 978-1-61896-421-2

(Paperback) USD 89.00

Authors/Editors Price: 40% off
Buy at: bookorder@scirp.org
Follow SCIRP
Contact us
book@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1243940697
Book Publishing WeChat
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top